← FDA Drug Approvals (Drugs@FDA)

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: B BRAUN MEDICAL · Approved 2025-05-01

Drug application

FDA Application #

ANDA218454

Application type

Abbreviated New Drug Application (Generic)

Brand name

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

Generic name

MIDAZOLAM IN 0.8% SODIUM CHLORIDE

Active ingredients

MIDAZOLAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

B BRAUN MEDICAL

Manufacturer

B. Braun Medical Inc.

First approval

2025-05-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown